EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway

Qinghua Tang iD, Yixiong Li, Yan Li, Xinyuan Wang, Yanan Bie, Xuesong Yu, Lin Zhou iD, Ming Li iD

International Journal of Molecular Sciences · 08.08.2026 · 27 (16) · 7109

DOI: 10.3390/ijms27167109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.08.2026. Verfasst von Qinghua Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Naphthoquinones, p38 Mitogen-Activated Protein Kinases, Nanoparticles, Psoriasis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Songgang People's Hospital, Bao'an District, Shenzhen, 2026 “Building Dreams, Setting Sail” Open Cooperation Fund for Scientific Research, Songgang People’s Hospital, Bao’an District, Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Di-(2-ethylhexyl) phthalate (DEHP), a ubiquitous environmental plasticizer, has been increasingly linked to the exacerbation of inflammatory skin conditions, especially psoriasis. However, the mechanisms and effective therapeutic strategies targeting DEHP-aggravated psoriasis remain elusive. We integrated network toxicology, network pharmacology, and molecular docking to explore the targets of DEHP-exacerbated psoriasis and the protective effects of shikonin (SH). These findings were validated in a DEHP/IMQ-induced mouse model using a novel shikonin nanoparticle (SH-NP) that overcomes SH’s inherent hydrophobicity. Computational analyses revealed that SH counteracts DEHP skin toxicity through a multi-target network, identifying the p38 mitogen-activated protein kinase (p38 MAPK), TNF, IL-1β, proliferating cell nuclear antigen (PCNA), and matrix metalloproteinases 2 and 9 (MMP2/9) as core therapeutic nodes. Molecular docking verified this network, revealing robust binding between SH and key targets with binding energies ranging from −6.0 to −7.8 kcal/mol, consistently outperforming DEHP. In vivo experiments demonstrated that topical application of SH-NP significantly ameliorated macroscopic skin injury and reduced PASI scores. Mechanistically, SH-NP effectively reversed the DEHP-exacerbated inflammatory microenvironment by decreasing macrophage and mast cell infiltration in the dermis, reducing pro-inflammatory cytokine levels, and inhibiting the phosphorylation of p38 MAPK. Furthermore, SH-NP treatment successfully suppressed keratinocyte hyperproliferation, as evidenced by downregulated PCNA expression and reduced epidermal thickness. SH-NPs also markedly downregulated the elevated levels of MMP2/9 in mice, thereby mitigating collagen degradation and maintaining dermal matrix integrity. This study shows that SH-NPs alleviate DEHP-aggravated psoriasis by suppressing local inflammation, keratinocyte hyperproliferation, and collagen degradation, offering a targeted nanostrategy for environmentally exacerbated skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Naphthoquinonesp38 Mitogen-Activated Protein KinasesNanoparticlesPsoriasisDiethylhexyl PhthalateSkinMAP Kinase Signaling SystemAnimalsMiceMolecular Docking SimulationDisease Models, AnimalHumansMaleMatrix Metalloproteinase 9Keratinocytes

Stichwörter der Autor:innen

di-(2-ethylhexyl) phthalate (DEHP)inflammatory microenvironmentp38 MAPK pathwaypsoriasisshikonin nanoparticles

Substanzen

Naphthoquinonesp38 Mitogen-Activated Protein KinasesshikoninDiethylhexyl PhthalateMatrix Metalloproteinase 9

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.
  • School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.
  • School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.

ORCID-Profile: Qinghua Tang, Lin Zhou, Ming Li

Förderung

  • Songgang People's Hospital, Bao'an District, Shenzhen
  • 2026 “Building Dreams, Setting Sail” Open Cooperation Fund for Scientific Research
  • Songgang People’s Hospital, Bao’an District, Shenzhen

Zitieren

APA

Tang, Q., Li, Y., Li, Y., Wang, X., Bie, Y., Yu, X., Zhou, L., & Li, M. (2026). Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway. International Journal of Molecular Sciences, 27(16), 7109. https://doi.org/10.3390/ijms27167109

Vancouver

Tang Q, Li Y, Li Y, Wang X, Bie Y, Yu X, et al. Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway. International Journal of Molecular Sciences. 2026;27(16):7109. doi:10.3390/ijms27167109

BibTeX
@article{Tang2026,
  author = {Tang, Qinghua and Li, Yixiong and Li, Yan and Wang, Xinyuan and Bie, Yanan and Yu, Xuesong and Zhou, Lin and Li, Ming},
  title = {Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7109},
  doi = {10.3390/ijms27167109}
}
Kostenlos starten →